CD4+ helper T cells, meanwhile, support CTL function through cytokine production (IL-2, IFN-γ) and promote memory formation—IMA901 peptide vaccine recipients with CD4+ responses showed improved overall survival in RCC trials [17]. This evidence concerns the gene CD4 and renal cell carcinoma.